MS&AD to reduce headcount by 6,300 by end of FY 2025
November 22 2022 by Andrew Tjaardstra
-
McLarens eyes acquisitions in non-claims technical advisory services
- November 12
The global adjuster identifies forensic engineering, quantity surviving and forensic accounting as potential areas interest for deals.
-
Cyber markets look to APAC for growth as market continues to soften
- November 8
As cyber insurance premiums are set to soar to US$20bn by 2026, the role of reinsurers and the importance of cyber hygiene in shaping the future of the market are becoming even more critical.
-
Suncorp’s Vero Insurance expands into specialty lines
- November 8
The first product to be launched will be high hazard property, which will focus more on businesses with more complex risk profiles rather than those exposed to higher natural hazard losses.
-
Miller Insurance sets sights on expansion in Japan and South Korea as it continues to plough its APAC furrow
- November 7
The broker is opening soon in South Korea and plans to “build pretty deep there”, and has some other plans in other territories to go too, said Ron Whyte.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
